Experience

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised Uniti Group Inc. in connection with an underwritten public offering of 19,528,302 shares of its common stock. Uniti intends to use the net proceeds from the offering to…

Davis Polk advised Murphy USA Inc. in connection with an SEC-registered offering of $300 million aggregate principal amount of 5.625% senior notes due 2027. The notes were issued by Murphy…

Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…

Davis Polk advised the sole underwriter on the $679.9 million SEC-registered offering by Cliffs Natural Resources Inc. of 63.25 million of its common shares. The amount sold includes 8.25…

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9 million initial public offering of common stock of Jounce Therapeutics,…

Davis Polk advised the sole underwriter in connection with a $201.25 million SEC-registered offering of 3,220,000 shares of common stock of Pinnacle Financial Partners, Inc. Included…

Davis Polk advised the joint lead dealer managers in connection with the registered offers by Johnson Controls International plc (“JCI plc”) to exchange certain outstanding debt securities…

Davis Polk advised Communications Sales & Leasing, Inc., as issuer, and CSL Capital, LLC, as co-issuer, in connection with the Rule 144A/Regulation S offering of $400 million aggregate…